Healthcare Sector Review: Winning and Losing Stocks on Dec 1st

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Amicus Therapeutics, Inc. (NASDAQ:FOLD): The shares closed at $3.18, up $0.32, or 11.19%, on the day. Its market capitalization is $110.20 million. About the company: Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease. Get the most recent company news and stock data here >>
  • GTx, Inc. (NASDAQ:GTXI): The shares closed at $2.96, up $0.24, or 8.82%, on the day. Its market capitalization is $185.86 million. About the company: GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men’s health conditions. The Company’s drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer. Get the most recent company news and stock data here >>
  • Momenta Pharmaceuticals (NASDAQ:MNTA): The shares closed at $16.25, up $1.21, or 8.05%, on the day. Its market capitalization is $832.67 million. About the company: Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products. Get the most recent company news and stock data here >>
  • Amarin Corp. plc (NASDAQ:AMRN): The shares closed at $7.43, up $0.45, or 6.45%, on the day. Its market capitalization is $1.01 billion. About the company: Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases. Get the most recent company news and stock data here >>
  • Incyte Corporation (NASDAQ:INCY): The shares closed at $14.44, up $0.67, or 4.87%, on the day. Its market capitalization is $1.82 billion. About the company: Incyte Corporation is using its expertise in genomics and medicinal chemistry, as well as molecular, cellular, and in vivo biology to discover and develop novel therapeutics. The Company has drug discovery programs underway focused on the identification of new small molecule drugs for cancer and inflammation. Get the most recent company news and stock data here >>

Losers (% price change)

  • Savient Pharmaceuticals (NASDAQ:SVNT): The shares closed at $2.29, down $0.22, or 8.76%, on the day. Its market capitalization is $163.67 million. About the company: Savient Pharmaceuticals Inc. develops, manufactures, and markets human health care products for niche and wider markets. The Company offers pharmaceutical products for a wide range of medical needs such as weight gain, drugs targeting the control of elevated uric acid levels in the blood, and rheumatology. Get the most recent company news and stock data here >>
  • Chindex Intl., Inc. (NASDAQ:CHDX): The shares closed at $8.50, down $0.72, or 7.81%, on the day. Its market capitalization is $142.74 million. About the company: Chindex International, Inc. provides representative and distribution services to a number of multinational companies in the Greater Chinese marketplace including Hong Kong and Macau. The Company also operates a private hospital corporation in China. U.S.-China’s customers include manufacturers of medical products. Get the most recent company news and stock data here >>
  • Delcath Systems, Inc. (NASDAQ:DCTH): The shares closed at $2.41, down $0.17, or 6.59%, on the day. Its market capitalization is $115.66 million. About the company: Delcath Systems Inc. has developed a system to isolate the liver from the circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. This system filters the patients blood removing most of the harmful chemotherapy agents lessening the side-effects of the treatment. Get the most recent company news and stock data here >>
  • Sunrise Senior Living (NYSE:SRZ): The shares closed at $4.73, down $0.3, or 5.96%, on the day. Its market capitalization is $272.63 million. About the company: Sunrise Senior Living, Inc. provides senior living services. The Company has various senior living communities either open or under construction in the United States, the United Kingdom, and Canada. Sunrise offers a range of senior living services, from independent living, to assisted living, to care for individuals with Alzheimer’s, and nursing and rehabilitative care. Get the most recent company news and stock data here >>
  • AVANIR Pharmaceuticals (NASDAQ:AVNR): The shares closed at $2.33, down $0.13, or 5.28%, on the day. Its market capitalization is $289.35 million. About the company: AVANIR Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More Articles About:   , , , , ,  

More from The Cheat Sheet